Schroder Investment Management Group
CLDX icon

Schroder Investment Management Group’s Celldex Therapeutics CLDX Stock Holding History

Schroder Investment Management Group’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-48,099
Closed -$1.26M – 1156
2025
Q3 		$1.26M Hold
48,099
– – ﹤0.01% 997
2025
Q2 		$979K Hold
48,099
– – ﹤0.01% 995
2025
Q1 		$959K Hold
48,099
– – ﹤0.01% 994
2024
Q4 		$1.21M Hold
48,099
– – ﹤0.01% 993
2024
Q3 		$1.6M Hold
48,099
– – ﹤0.01% 970
2024
Q2 		$1.78M Hold
48,099
– – ﹤0.01% 944
2024
Q1 		$2.02M Hold
48,099
– – ﹤0.01% 922
2023
Q4 		$1.91M Buy
+48,099
New +$1.41M ﹤0.01% 917
2014
Q4 		– Sell
-1,500
Closed -$292K – 1364
2014
Q3 		$292K Hold
1,500
– – ﹤0.01% 1143
2014
Q2 		$367K Hold
1,500
– – ﹤0.01% 1093
2014
Q1 		$398K Hold
1,500
– – ﹤0.01% 1101
2013
Q4 		$545K Hold
1,500
– – ﹤0.01% 1102
2013
Q3 		$797K Buy
+1,500
New +$514K ﹤0.01% 1044

Other funds holding CLDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return